Persavita

Persavita is a Canadian health and nutraceutical company focused primarily on eye health, especially age-related macular degeneration and related retinal aging conditions. The company markets consumer eye-health supplements under the Saffron 2020 brand family, including formulations positioned around saffron and AREDS2-aligned ingredients such as lutein and zeaxanthin. Persavita also offers an AMD Companion digital wellness tool intended to support patient education and daily habit formation for people with macular degeneration. Historically, the company announced plans for a Phase 2 Health Canada-authorized clinical study of an experimental natural health product for COVID-19, but its currently visible commercial emphasis appears to be direct-to-consumer eye-health products rather than a traditional drug-development pipeline. Overall, Persavita looks more like a science-backed consumer health and vision-support company than a conventional biotech or pharmaceutical developer.